EZH2 oncogenic mutations drive epigenetic, transcriptional, and structural changes within chromatin domains

被引:99
作者
Donaldson-Collier, Maria C. [1 ]
Sungalee, Stephanie [1 ]
Zufferey, Marie [2 ,3 ]
Tavernari, Daniele [2 ,3 ]
Katanayeva, Natalya [1 ]
Battistello, Elena [1 ,2 ,3 ]
Mina, Marco [2 ,3 ]
Douglass, Kyle M. [4 ]
Rey, Timo [4 ]
Raynaud, Franck [2 ,3 ]
Manley, Suliana [4 ]
Ciriello, Giovanni [2 ,3 ]
Oricchio, Elisa [1 ]
机构
[1] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res ISREC, Sch Life Sci, Lausanne, Switzerland
[2] Univ Lausanne UNIL, Dept Computat Biol, Lausanne, Switzerland
[3] SIB, Lausanne, Switzerland
[4] Ecole Polytech Fed Lausanne, Inst Phys, Lausanne, Switzerland
基金
瑞士国家科学基金会; 欧盟地平线“2020”;
关键词
TOPOLOGICAL DOMAINS; TUMOR-SUPPRESSOR; GENOME; PRINCIPLES; ORGANIZATION; ACTIVATION; LANDSCAPE; LYMPHOMA; DEFINES; TARGET;
D O I
10.1038/s41588-018-0338-y
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Chromatin is organized into topologically associating domains (TADs) enriched in distinct histone marks. In cancer, gain-of-function mutations in the gene encoding the enhancer of zeste homolog 2 protein (EZH2) lead to a genome-wide increase in histone-3 Lys27 trimethylation (H3K27me3) associated with transcriptional repression. However, the effects of these epigenetic changes on the structure and function of chromatin domains have not been explored. Here, we found a functional interplay between TADs and epigenetic and transcriptional changes mediated by mutated EZH2. Altered EZH2 (p.Tyr646* (EZH2(Y646X))) led to silencing of entire domains, synergistically inactivating multiple tumor suppressors. Intra-TAD gene silencing was coupled with changes of interactions between gene promoter regions. Notably, gene expression and chromatin interactions were restored by pharmacological inhibition of EZH2(Y646X). Our results indicate that EZH2(Y646X) alters the topology and function of chromatin domains to promote synergistic oncogenic programs.
引用
收藏
页码:517 / +
页数:15
相关论文
共 54 条
[1]   EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation [J].
Beguelin, Wendy ;
Popovic, Relja ;
Teater, Matt ;
Jiang, Yanwen ;
Bunting, Karen L. ;
Rosen, Monica ;
Shen, Hao ;
Yang, Shao Ning ;
Wang, Ling ;
Ezponda, Teresa ;
Martinez-Garcia, Eva ;
Zhang, Haikuo ;
Zheng, Yupeng ;
Verma, Sharad K. ;
McCabe, Michael T. ;
Ott, Heidi M. ;
Van Aller, Glenn S. ;
Kruger, Ryan G. ;
Liu, Yan ;
McHugh, Charles F. ;
Scott, David W. ;
Chung, Young Rock ;
Kelleher, Neil ;
Shaknovich, Rita ;
Creasy, Caretha L. ;
Gascoyne, Randy D. ;
Wong, Kwok-Kin ;
Cerchietti, Leandro ;
Levine, Ross L. ;
Abdel-Wahab, Omar ;
Licht, Jonathan D. ;
Elemento, Olivier ;
Melnick, Ari M. .
CANCER CELL, 2013, 23 (05) :677-692
[2]   Super-resolution imaging reveals distinct chromatin folding for different epigenetic states [J].
Boettiger, Alistair N. ;
Bintu, Bogdan ;
Moffitt, Jeffrey R. ;
Wang, Siyuan ;
Beliveau, Brian J. ;
Fudenberg, Geoffrey ;
Imakaev, Maxim ;
Mirny, Leonid A. ;
Wu, Chao-ting ;
Zhuang, Xiaowei .
NATURE, 2016, 529 (7586) :418-+
[3]   Organization and function of the 3D genome [J].
Bonev, Boyan ;
Cavalli, Giacomo .
NATURE REVIEWS GENETICS, 2016, 17 (11) :661-678
[4]   p53 target genes Sestrin1 and Sestrin2 connect genotoxic stress and mTOR signaling [J].
Budanov, Andrei V. ;
Karin, Michael .
CELL, 2008, 134 (03) :451-460
[5]   An integrated model for detecting significant chromatin interactions from high-resolution Hi-C data [J].
Carty, Mark ;
Zamparo, Lee ;
Sahin, Merve ;
Gonzalez, Alvaro ;
Pelossof, Raphael ;
Elemento, Olivier ;
Leslie, Christina S. .
NATURE COMMUNICATIONS, 2017, 8
[6]   Variability in DNA methylation defines novel epigenetic subgroups of DLBCL associated with different clinical outcomes [J].
Chambwe, Nyasha ;
Kormaksson, Matthias ;
Geng, Huimin ;
De, Subhajyoti ;
Michor, Franziska ;
Johnson, Nathalie A. ;
Morin, Ryan D. ;
Scott, David W. ;
Godley, Lucy A. ;
Gascoyne, Randy D. ;
Melnick, Ari ;
Campagne, Fabien ;
Shaknovich, Rita .
BLOOD, 2014, 123 (11) :1699-1708
[7]   F-box protein FBXL2 exerts human lung tumor suppressor-like activity by ubiquitin-mediated degradation of cyclin D3 resulting in cell cycle arrest [J].
Chen, B. B. ;
Glasser, J. R. ;
Coon, T. A. ;
Mallampalli, R. K. .
ONCOGENE, 2012, 31 (20) :2566-2579
[8]   Maintaining cell identity: PRC2-mediated regulation of transcription and cancer [J].
Comet, Itys ;
Riising, Eva M. ;
Leblanc, Benjamin ;
Helin, Kristian .
NATURE REVIEWS CANCER, 2016, 16 (12) :803-810
[9]   Unravelling the tumor-suppressive functions of FOXO proteins [J].
Dansen, Tobias B. ;
Burgering, Boudewijn M. T. .
TRENDS IN CELL BIOLOGY, 2008, 18 (09) :421-429
[10]   Genome-wide characterization of mammalian promoters with distal enhancer functions [J].
Dao, Lan T. M. ;
Galindo-Albarran, Ariel O. ;
Castro-Mondragon, Jaime A. ;
Andrieu-Soler, Charlotte ;
Medina-Rivera, Alejandra ;
Souaid, Charbel ;
Charbonnier, Guillaume ;
Griffon, Aurelien ;
Vanhille, Laurent ;
Stephen, Tharshana ;
Alomairi, Jaafar ;
Martin, David ;
Torres, Magali ;
Fernandez, Nicolas ;
Soler, Eric ;
van Helden, Jacques ;
Puthier, Denis ;
Spicuglia, Salvatore .
NATURE GENETICS, 2017, 49 (07) :1073-+